D
Quince Therapeutics, Inc. QNCX
$1.63 $0.021.24% NASDAQ
Recommendation
Prev Close
$1.63
Volume
178,502
Avg Vol (90D)
317,280
Market Cap
$87.55M
Dividend & Yield
--
52-Week Range
$0.61 - $2.45
P/E (TTM)
--
EPS (TTM)
-$1.10
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
QNCX Q3 EPS Estimate Lifted by Brookline Capital Management
8/17/2025 - MarketBeat
Quince Therapeutics (NASDAQ:QNCX) Receives "Buy" Rating from D. Boral Capital
8/17/2025 - MarketBeat
QNCX FY2029 EPS Increased by Brookline Capital Management
8/16/2025 - MarketBeat
Quince Therapeutics (QNCX) Maintains 'Buy' Rating and Price Target QNCX Stock News
8/15/2025 - GuruFocus
Quince Therapeutics (NASDAQ:QNCX) Price Target Cut to $8.00 by Analysts at JMP Securities
8/13/2025 - MarketBeat
Quince Therapeutics (NASDAQ:QNCX) Posts Quarterly Earnings Results, Misses Estimates By $0.06 EPS
8/13/2025 - MarketBeat
Quince Therapeutics price target lowered by $1 at Citizens JMP, here's why
8/12/2025 - The Fly
Quince Therapeutics Reports Q2 2025 Net Loss of $0.34 Per Share, Missing EPS Estimate of -$0.26
8/11/2025 - GuruFocus
Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
8/11/2025 - GuruFocus
Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results ...
8/11/2025 - GuruFocus
Quince Therapeutics reports Q2 EPS (34c), consensus (23c)
8/11/2025 - The Fly
Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
8/11/2025 - Business Wire
How Option Care Health's Partnership for eDSP Therapy Could Shape Expansion Plans for OPCH Investors
8/11/2025 - Simply Wall St
Should Option Care Health's (OPCH) Quince Partnership Shape Its Narrative as a Leader in Infusion Services?
8/9/2025 - Simply Wall St
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for ...
8/7/2025 - GuruFocus
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for ...
8/7/2025 - GuruFocus
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP
8/7/2025 - Business Wire
Quince Therapeutics (QNCX) Projected to Post Earnings on Tuesday
8/6/2025 - MarketBeat
JMP Securities Begins Coverage on Quince Therapeutics (NASDAQ:QNCX)
8/6/2025 - MarketBeat
Citizens Jmp Begins Coverage on Quince Therapeutics (NASDAQ:QNCX)
8/6/2025 - MarketBeat
Quince Therapeutics, Inc. (NASDAQ:QNCX) Short Interest Up 64.5% in July
8/6/2025 - Ticker Report
Quince Therapeutics, Inc. (NASDAQ:QNCX) Short Interest Up 64.5% in July
8/6/2025 - MarketBeat
Quince Therapeutics (QNCX) Receives Positive Coverage with Strong Growth Potential
8/5/2025 - GuruFocus
Quince Therapeutics initiated with bullish view at Citizens JMP, here's why
8/5/2025 - The Fly
Quince Therapeutics registers up to 17.3M shares for resale by investors
7/25/2025 - Seeking Alpha - Healthcare
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$38.82M
EBIT (TTM)
-$38.98M
Net Income (TTM)
-$49.03M
Balance Sheet
Total Assets (Q)
$117.21M
Total Debt (Q)
$17.49M
Total Liabilities (Q)
$105.47M
Book Value Per Share (Q)
$0.2189
Cash Flow
Cash from Operations (TTM)
-$35.83M
Cash from Investing (TTM)
$34.91M
Cash from Financing (TTM)
$9.50M
Net Change in Cash (TTM)
$8.94M
Filings
Filing Date
Monday, August 11, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Loading...
Beta
-0.34
7-Day Total Return
-2.98%
30-Day Total Return
-8.43%
60-Day Total Return
56.73%
90-Day Total Return
61.39%
Year to Date Total Return
-13.30%
1-Year Total Return
146.97%
2-Year Total Return
28.35%
3-Year Total Return
-14.66%
5-Year Total Return
-96.13%
52-week Low
Aug 26, 2024 - $0.61
52-week High
Nov 22, 2024 - $2.45
Valuation
Market Cap
$87.55M - Micro Cap
Enterprise Value
$70.33M
Price/Sales (TTM)
--
Price/Book (Q)
7.45
Dividends and Shares
Shares Outstanding
46.69
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.quincetx.com
Phone Number
415 910 5717
Address
611 Gateway Boulevard
South San Francisco, CA 94080
Country
United States
Year Founded
2012
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead... more
NASDAQ 08/22/2025 4:00PM Eastern Quotes delayed